Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Laboratoires Serb SAS

www.serb-labo.com

Latest From Meadox Medicals Inc.

Filling in the Gaps in AAA Repair

The first stent grafts created a market for the endovascular repair of abdominal aortic aneurysms. They also created new problems for start-ups to overcome. New companies have risen to the problem of avoiding endoleaks, with new stent graft designs and attachment systems, and also solutions for continuous monitoring.
Medical Device

Spine's Next Generation

As the growth of the spine market outpaces virtually every other orthopedic segment, spine companies are hot. But the challenges that small spine start-ups face aren't only technological; they're also competitive as the market is defined by large spine players and a host of major orthopedic companies looking to tap into spine's potential.
Medical Device Strategy

NuVasive Inc.

Nuvasive Inc. is developing a platform for minimally invasive spine surgery that combines stereotactic guidance with a neural monitoring system. With neural monitoring, surgeons can access the spine laterally, as opposed to from the back, which entails cutting through bone and splitting muscles. In this way, Nuvasive is advancing medical practice beyond merely replacing the open surgical view with endoscopic access, but otherwise leaving the fusion procedure unchanged.
Medical Device Innovation

AAA and Vascular Device Start-Ups

The first generation less-invasive devices for abdominal aortic aneurysm (AAA) surgery haven't yet been approved and the next generation is already here.
Medical Device
See All

Company Information

  • Industry
  • Pharmaceuticals
    • Specialty Pharmaceuticals
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • France
  • Parent & Subsidiaries
  • Laboratoires Serb SAS
  • Senior Management
  • Jeremie Urbain, CEO
  • Contact Info
  • Laboratoires Serb SAS
    Phone: 1 44 62 55 00
    53, rue Villiers de L'Isle-Adam
    Paris, 75020
    France
Advertisement
Advertisement
UsernamePublicRestriction

Register